Rajendra R. Makkar

Rajendra R. Makkar's AcademicInfluence.com Rankings

Rajendra R. Makkar

Engineering

#5663

World Rank

#6927

Historical Rank

Biomedical Engineering

#452

World Rank

#461

Historical Rank

engineering Degrees

Rajendra R. Makkar

Philosophy

#7829

World Rank

#11094

Historical Rank

Logic

#4864

World Rank

#6196

Historical Rank

philosophy Degrees

Download Badge

Engineering
Philosophy

Why Is Rajendra R. Makkar Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Rajendra R. Makkar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. (2010) (6019)
Transcatheter versus surgical aortic-valve replacement in high-risk patients. (2011) (5212)
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. (2016) (3614)
Transcatheter Aortic‐Valve Replacement with a Balloon‐Expandable Valve in Low‐Risk Patients (2019) (2461)
Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients (2017) (1992)
Two-year outcomes after transcatheter or surgical aortic-valve replacement. (2012) (1727)
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial (2012) (1359)
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial (2015) (1308)
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. (2012) (1186)
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis (2016) (877)
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial (2015) (715)
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. (2015) (711)
Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study (2017) (636)
Two-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement (2013) (597)
Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. (2013) (477)
Cross-sectional computed tomographic assessment improves accuracy of aortic annular sizing for transcatheter aortic valve replacement and reduces the incidence of paravalvular aortic regurgitation. (2012) (468)
Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. (2012) (450)
Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). (2014) (449)
Anatomical and Procedural Features Associated With Aortic Root Rupture During Balloon-Expandable Transcatheter Aortic Valve Replacement (2013) (447)
Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. (2015) (423)
Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. (2020) (356)
Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement. (2017) (345)
Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. (2006) (342)
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis. (2017) (315)
Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. (2016) (301)
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. (2009) (300)
Health-Related Quality of Life After Transcatheter Aortic Valve Replacement in Inoperable Patients With Severe Aortic Stenosis (2011) (295)
Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue (2009) (288)
Prosthetic Heart Valve Thrombosis. (2016) (278)
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. (2019) (272)
Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry. (2017) (257)
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification. (2018) (252)
Staging classification of aortic stenosis based on the extent of cardiac damage (2017) (246)
Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. (2021) (236)
Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. (2011) (235)
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification (2018) (222)
Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death. (2016) (221)
Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry (2018) (220)
Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves). (2013) (219)
Mitral Annulus Calcification. (2015) (202)
Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. (2006) (198)
Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. (2021) (189)
Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. (2014) (186)
Coronary Obstruction in Transcatheter Aortic Valve-in-Valve Implantation: Preprocedural Evaluation, Device Selection, Protection, and Treatment (2015) (180)
Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings. (2017) (175)
Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke. (2019) (166)
A Bicuspid Aortic Valve Imaging Classification for the TAVR Era. (2016) (162)
One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis (2016) (161)
Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). (2014) (158)
A Highly Predictive Risk Model for Pacemaker Implantation After TAVR. (2017) (157)
Aortic annular sizing for transcatheter aortic valve replacement using cross-sectional 3-dimensional transesophageal echocardiography. (2013) (156)
Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement. (2019) (151)
Natural history of subclinical leaflet thrombosis affecting motion in bioprosthetic aortic valves (2017) (149)
Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy (2014) (149)
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. (2019) (146)
Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. (2012) (142)
Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: a study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). (2013) (141)
Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2012) (139)
The Fluid Mechanics of Transcatheter Heart Valve Leaflet Thrombosis in the Neosinus (2017) (134)
Impact of Preoperative Moderate/Severe Mitral Regurgitation on 2-Year Outcome After Transcatheter and Surgical Aortic Valve Replacement: Insight From the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A (2013) (131)
A revised methodology for aortic-valvar complex calcium quantification for transcatheter aortic valve implantation. (2014) (130)
Mesenchymal Stem Cell Injection Induces Cardiac Nerve Sprouting and Increased Tenascin Expression in a Swine Model of Myocardial Infarction (2003) (130)
Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial (2018) (124)
Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations. (2014) (124)
Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The TOPAS-TAVI Registry. (2018) (124)
Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve (2017) (123)
Intramyocardial Injection of Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Without Immunosuppression Preserves Cardiac Function in a Porcine Model of Myocardial Infarction (2005) (122)
Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves: PARTNER 3 Cardiac Computed Tomography Substudy. (2020) (122)
Insights Into Timing, Risk Factors, and Outcomes of Stroke and Transient Ischemic Attack After Transcatheter Aortic Valve Replacement in the PARTNER Trial (Placement of Aortic Transcatheter Valves) (2016) (122)
Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures. (2017) (120)
Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. (2021) (116)
Stem-Cell Transplantation in Myocardial Infarction: A Status Report (2004) (114)
Systematic CT Methodology for the Evaluation of Subclinical Leaflet Thrombosis. (2017) (111)
Chronic pacing and adverse outcomes after transcatheter aortic valve implantation (2015) (111)
A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery. (2015) (103)
Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. (2011) (102)
Meta-analysis of incidence, clinical characteristics and implications of stent fracture. (2010) (98)
Validation of Contrast-Enhanced Magnetic Resonance Imaging to Monitor Regenerative Efficacy After Cell Therapy in a Porcine Model of Convalescent Myocardial Infarction (2013) (97)
Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. (2008) (96)
Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial (2019) (96)
Concomitant mitral annular calcification and severe aortic stenosis: prevalence, characteristics and outcome following transcatheter aortic valve replacement (2016) (94)
Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial (2017) (94)
Long-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial. (2016) (92)
Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). (2014) (92)
Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study. (2017) (88)
Bicuspid Aortic Valve Morphology and Outcomes After Transcatheter Aortic Valve Replacement. (2020) (84)
Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. (2015) (83)
Stem cell therapy for myocardial repair: is it arrhythmogenic? (2003) (82)
Cellular Postconditioning: Allogeneic Cardiosphere-Derived Cells Reduce Infarct Size and Attenuate Microvascular Obstruction When Administered After Reperfusion in Pigs With Acute Myocardial Infarction (2015) (82)
Outcomes with post-dilation following transcatheter aortic valve replacement: the PARTNER I trial (placement of aortic transcatheter valve). (2014) (81)
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve. (2020) (81)
Coronary Access After TAVR. (2020) (81)
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial. (2019) (80)
Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure (2016) (79)
Comprehensive analysis of mortality among patients undergoing TAVR: results of the PARTNER trial. (2014) (79)
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous (2013) (78)
Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial. (2020) (78)
The impact of calcium volume and distribution in aortic root injury related to balloon-expandable transcatheter aortic valve replacement. (2015) (78)
Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy. (2015) (76)
Transcatheter Valve-in-Ring Implantation for the Treatment of Residual or Recurrent Tricuspid Valve Dysfunction After Prior Surgical Repair. (2017) (74)
Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration). (2019) (74)
Aortic Angulation Attenuates Procedural Success Following Self-Expandable But Not Balloon-Expandable TAVR. (2016) (73)
Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis (2019) (73)
Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. (2007) (73)
Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry. (2016) (73)
Commissural Alignment of Bioprosthetic Aortic Valve and Native Aortic Valve Following Surgical and Transcatheter Aortic Valve Replacement and its Impact on Valvular Function and Coronary Filling. (2018) (71)
ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) Trial: Rationale and Design (2017) (71)
Short‐term results of alcohol septal ablation as a bail‐out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification (2017) (71)
Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Success and safety (2016) (70)
Porcelain Aorta: A Comprehensive Review (2015) (67)
Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial (2017) (67)
Intrinsic cardiac origin of human cardiosphere-derived cells. (2013) (66)
Impact of Preoperative Chronic Kidney Disease in 2,531 High-Risk and Inoperable Patients Undergoing Transcatheter Aortic Valve Replacement in the PARTNER Trial. (2016) (64)
Chimney Stenting for Coronary Occlusion During TAVR: Insights From the Chimney Registry. (2020) (64)
Clinical impact of coronary protection during transcatheter aortic valve implantation: first reported series of patients. (2015) (63)
Stratification of outcomes after transcatheter aortic valve replacement according to surgical inoperability for technical versus clinical reasons. (2014) (62)
Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. (2013) (61)
Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Technical performance (2016) (59)
Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial. (2020) (58)
The relative performance characteristics of the logistic European System for Cardiac Operative Risk Evaluation score and the Society of Thoracic Surgeons score in the Placement of Aortic Transcatheter Valves trial. (2014) (58)
Infective Endocarditis After Transcatheter Aortic Valve ImplantationCLINICAL PERSPECTIVE (2015) (56)
Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from the PARTNER Trials. (2019) (55)
Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis. (2019) (55)
Stem cell transplantation for myocardial infarction? (2004) (55)
Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial). (2015) (53)
Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial (2019) (50)
Transcatheter Edge-to-Edge Mitral Valve Repair With the MitraClip G4 System. (2020) (49)
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients (2020) (49)
Outcomes From Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis and Left Ventricular Ejection Fraction Less Than 30%: A Substudy From the TOPAS-TAVI Registry (2019) (47)
In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves. (2016) (46)
Comparison of SAPIEN 3 and SAPIEN XT transcatheter heart valve stent-frame expansion: evaluation using multi-slice computed tomography (2016) (44)
Allogeneic Cardiospheres Delivered via Percutaneous Transendocardial Injection Increase Viable Myocardium, Decrease Scar Size, and Attenuate Cardiac Dilatation in Porcine Ischemic Cardiomyopathy (2014) (44)
Transcatheter aortic valve replacement for stenotic bicuspid aortic valves: Systematic review and meta analyses of observational studies (2018) (43)
Effect of Transcatheter Aortic Valve Replacement on the Mitral Valve Apparatus and Mitral Regurgitation: Real-Time Three-Dimensional Transesophageal Echocardiography Study (2014) (43)
Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series (2020) (43)
Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial. (2018) (43)
Health Status after Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis. (2019) (43)
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial (2020) (41)
Transfemoral access assessment for transcatheter aortic valve replacement: evidence-based application of computed tomography over invasive angiography. (2014) (40)
Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves). (2015) (40)
Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial (2019) (40)
Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial. (2015) (40)
International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. (2021) (40)
Long-term outcome of stem cell therapy for acute myocardial infarction: right results, wrong reasons. (2009) (39)
Risk of Coronary Obstruction Due to Sinus Sequestration in Redo Transcatheter Aortic Valve Replacement. (2020) (39)
Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation. (2019) (38)
Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts. (2018) (38)
Computed tomography characteristics of the aortic valve and the geometry of SAPIEN 3 transcatheter heart valve in patients with bicuspid aortic valve disease (2018) (38)
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography. (2020) (38)
Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical Trial (2019) (37)
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass (2014) (37)
Percutaneous left ventricular support devices. (2006) (36)
Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses. (2019) (35)
Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Implantation. (2016) (34)
Comparison of Outcomes of Transcatheter Aortic Valve Implantation in Patients ≥90 Years Versus <90 Years. (2015) (34)
Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement (2021) (34)
Coronary Protection to Prevent Coronary Obstruction During TAVR (2020) (33)
Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT II. (2021) (32)
Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy). (2014) (31)
Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement. (2018) (31)
Impact of Aortic Root Anatomy and Geometry on Paravalvular Leak in Transcatheter Aortic Valve Replacement With Extremely Large Annuli Using the Edwards SAPIEN 3 Valve. (2018) (31)
Durable Benefits of Cellular Postconditioning: Long‐Term Effects of Allogeneic Cardiosphere‐Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction (2016) (31)
Learning curves for transapical transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance, success, and safety. (2016) (30)
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement. (2019) (30)
New paradigms of myocardial regeneration post-infarction: tissue preservation, cell environment, and pluripotent cell sources. (2009) (29)
Impact of Preprocedural B-Type Natriuretic Peptide Levels on the Outcomes After Transcatheter Aortic Valve Implantation. (2015) (28)
Outcomes after transfemoral transcatheter aortic valve replacement: a comparison of the randomized PARTNER (Placement of AoRTic TraNscathetER Valves) trial with the NRCA (Nonrandomized Continued Access) registry. (2014) (28)
Hybrid revascularization using percutaneous coronary intervention and robotically assisted minimally invasive direct coronary artery bypass surgery. (2004) (28)
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry. (2016) (28)
The outcomes of transcatheter aortic valve replacement in a cohort of patients with end‐stage renal disease (2016) (27)
Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology (2016) (27)
Heart-rate adjustment of transcatheter haemodynamics improves the prognostic evaluation of paravalvular regurgitation after transcatheter aortic valve implantation. (2015) (27)
Assessment of Post-Procedural Aortic Regurgitation After TAVR: An Intraprocedural TEE Study. (2015) (26)
Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke Among Patients at Low Surgical Risk. (2021) (26)
Cardiopulmonary bypass and intra‐aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: A PARTNER trial substudy (2015) (25)
Valve hemodynamic deterioration and cardiovascular outcomes in TAVR: A report from the STS/ACC TVT Registry (2018) (25)
Outcomes in 937 Intermediate-Risk Patients Undergoing Surgical Aortic Valve Replacement in PARTNER-2A. (2017) (24)
International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. (2021) (23)
Treatment of coronary aneurysm in acute myocardial infarction with AngioJet thrombectomy and JoStent coronary stent graft. (2004) (22)
Abstract 20536: ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR): the One Year Phase I Results (2014) (22)
Impact of device landing zone calcification on paravalvular regurgitation after transcatheter aortic valve replacement: a real-time three-dimensional transesophageal echocardiographic study. (2015) (21)
A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial. (2021) (20)
Impact of body mass index on the outcomes following transcatheter aortic valve implantation (2016) (20)
Timing and Outcomes of Percutaneous Coronary Intervention in Patients Who Underwent Transcatheter Aortic Valve Implantation. (2020) (20)
Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry (2017) (20)
Safety Profile of an Intra-Annular Self-Expanding Transcatheter Aortic Valve and Next-Generation Low-Profile Delivery System. (2020) (20)
Relation Between Left Ventricular Outflow Tract Calcium and Mortality Following Transcatheter Aortic Valve Implantation. (2017) (19)
Feasibility and safety of balloon-expandable transcatheter aortic valve implantation with moderate or without predilatation. (2016) (19)
Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. (2016) (19)
Correlation of echo-Doppler aortic valve regurgitation index with angiographic aortic regurgitation severity. (2003) (18)
Clinical outcomes and prognostic factors of transcatheter aortic valve implantation in bicuspid aortic valve patients. (2017) (17)
Allogeneic Cardiosphere-derived Cells for the Treatment of Heart Failure with Reduced Ejection Fraction: Results of the Dilated cardiomYopathy iNtervention with Allogeneic Myocardially-regeneratIve Cells (DYNAMIC) trial. (2019) (16)
Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement. (2022) (16)
Mid-Term Outcomes of Transcatheter Aortic Valve Replacement in Extremely Large Annuli With Edwards SAPIEN 3 Valve. (2019) (16)
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI. (2021) (16)
The role of flow stasis in transcatheter aortic valve leaflet thrombosis. (2020) (16)
Severe aortic stenosis with low aortic valve calcification: characteristics and outcome following transcatheter aortic valve implantation (2017) (16)
New strategies in the percutaneous management of coronary artery fistulae: A case report (2004) (16)
Leaflet immobility and thrombosis in transcatheter aortic valve replacement (2020) (15)
Optimal sizing for SAPIEN 3 transcatheter aortic valve replacement in patients with or without left ventricular outflow tract calcification. (2017) (15)
Valve‐in‐Valve for Degenerated Transcatheter Aortic Valve Replacement Versus Valve‐in‐Valve for Degenerated Surgical Aortic Bioprostheses: A 3‐Center Comparison of Hemodynamic and 1‐Year Outcome (2020) (15)
Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic Stenosis. (2020) (15)
3D Assessment of Features Associated With Transvalvular Aortic Regurgitation After TAVR: A Real-Time 3D TEE Study. (2016) (15)
Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience. (2022) (15)
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry. (2020) (15)
Pre-procedural administration of aminophylline does not prevent AngioJet rheolytic thrombectomy-induced bradyarrhythmias. (2005) (15)
Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients With Transcatheter Aortic Valve Implantation (2021) (15)
AngioJet thrombectomy. (2004) (15)
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results. (2022) (15)
Percutaneous paravalvular leak closure for balloon-expandable transcatheter aortic valve replacement: a comparison with surgical aortic valve replacement paravalvular leak closure. (2015) (14)
Permanent-temporary pacemakers in the management of patients with conduction abnormalities after transcatheter aortic valve replacement (2018) (14)
Effect of ascending aortic dimension on acute procedural success following self-expanding transcatheter aortic valve replacement: A multicenter retrospective analysis. (2017) (14)
Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement. (2022) (14)
Transseptal closure of left ventricular pseudoaneurysm post-transapical transcatheter aortic valve replacement. (2014) (14)
Outcomes of Self-Expanding vs. Balloon-Expandable Transcatheter Heart Valves for the Treatment of Degenerated Aortic Surgical Bioprostheses　- A Propensity Score-Matched Comparison. (2018) (13)
TCT-8 Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System (2019) (13)
Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry. (2020) (13)
Valve-in-Surgical-Valve With SAPIEN 3 for Transcatheter Aortic Valve Replacement Based on Society of Thoracic Surgeons Predicted Risk of Mortality (2021) (13)
Prognostic impact of aortic regurgitation after transcatheter aortic valve implantation. (2012) (13)
Neosinus Flow Stasis Correlates With Thrombus Volume Post-TAVR: A Patient-Specific In Vitro Study. (2019) (13)
The effect of granulocyte colony stimulating factor on regional and global myocardial function in the porcine infarct model. (2007) (13)
Transcatheter Aortic Valve Replacement Using the Portico System: 10 Things to Remember. (2016) (12)
Prognostic Value of Increased Mitral Valve Gradient After Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation. (2022) (12)
Diagnosis and Outcomes of Transcatheter Aortic Valve Implantation in Bicuspid Aortic Valve Stenosis. (2018) (12)
The PARTNER 3 Bicuspid Registry for Transcatheter Aortic Valve Replacement in Low-Surgical-Risk Patients. (2022) (12)
Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement (2020) (12)
Sapien 3 Transcatheter Aortic Valve Implantation With Moderate or Without Predilation. (2016) (12)
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. (2016) (12)
Transcatheter Aortic Valve Replacement With Different Valve Types in Elliptic Aortic Annuli. (2017) (12)
Early commercial experience from transcatheter aortic valve implantation using the Portico™ bioprosthetic valve: 30-day outcomes in the multicentre PORTICO-1 study. (2018) (11)
Partial restoration of myocardial function and perfusion by cell therapy following myocardial infarction (2004) (11)
Transcatheter Aortic Valve Thrombosis: New Problem, New Insights. (2017) (11)
International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. (2021) (11)
Characterization of aortic root geometry in transcatheter aortic valve replacement patients (2018) (11)
Transcatheter Aortic Valve Replacement Outcomes in Patients With Native vs Transplanted Kidneys: Data From an International Multicenter Registry. (2019) (11)
Design and Rationale of the XIENCE Short DAPT Clinical Program: an Assessment of the Safety of 3-month or 1-month DAPT in Patients at High Bleeding Risk Undergoing PCI with an Everolimus-Eluting Stent. (2020) (11)
Transcatheter Aortic Valve Replacement for Bicuspid Aortic Stenosis: Are We Ready for the Challenge? (2016) (11)
Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon‐Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning (2018) (10)
Characteristics and outcome following transcatheter aortic valve replacement in patients with severe aortic stenosis with low flow. (2017) (10)
Predictors and Outcomes of Persistent Tricuspid Regurgitation After Transcatheter Aortic Valve Implantation. (2019) (10)
Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation. (2022) (10)
Will PARTNER change my practice? Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A trial - transcatheter or surgical aortic-valve replacement in intermediate-risk patients. (2016) (10)
Stem-cell repair of infarcted myocardium: ready for clinical application? (2004) (10)
Significant Reduction in Mitral Regurgitation Volume Is the Main Contributor for Increase in Systolic Forward Flow in Patients with Functional Mitral Regurgitation after Transcatheter Aortic Valve Replacement: Hemodynamic Analysis Using Echocardiography (2015) (9)
Coronary perforation after percutaneous coronary intervention successfully treated with local thrombin injection. (2006) (9)
TCT-820 Multivessel Intracoronary Infusion of Allogeneic Cardiosphere Derived Cells in Dilated Cardiomyopathy: Long Term Outcomes of the Dilated Cardiomyopathy Intervention with Allogeneic Myocardially-Regenerative Cells (DYNAMIC Trial). (2016) (9)
Outcome of paravalvular leak repair after transcatheter aortic valve replacement with a balloon‐expandable prosthesis (2017) (9)
The clinical impact of vascular complications as defined by VARC-1 vs. VARC-2 in patients following transcatheter aortic valve implantation. (2016) (9)
INTRACORONARY CARDIOSPHERE-DERIVED CELLS AFTER MYOCARDIAL INFARCTION: MAGNETIC RESONANCE IMAGING ANALYSIS OF REGENERATION AND DETERMINANTS OF EFFICACY IN THE FINAL 1-YEAR RESULTS OF THE CADUCEUS TRIAL (2013) (9)
Prognostic Impact of Permanent Pacemaker Implantation in Patients With Low Left Ventricular Ejection Fraction Following Transcatheter Aortic Valve Replacement. (2019) (9)
Long-Term Outcomes After Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2020) (9)
Computed tomography angiography-derived extracellular volume fraction predicts early recovery of left ventricular systolic function after transcatheter aortic valve replacement. (2020) (9)
Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2021) (9)
Clinical Outcomes of TAVI or SAVR in Men and Women with Aortic Stenosis at Intermediate Operative Risk: a post hoc analysis of the randomized SURTAVI trial. (2020) (8)
Commissural Alignment After Balloon-Expandable Transcatheter Aortic Valve Replacement Is Associated With Improved Hemodynamic Outcomes. (2022) (8)
TCT-107 Transcatheter Aortic Valve Replacement with a Self-Expanding Prosthesis or Surgical Aortic Valve Replacement in Intermediate-Risk Patients: Complete 1-Year Outcomes from the SURTAVI Trial (2017) (8)
Alternative access for balloon-expandable transcatheter aortic valve replacement: comparison of the transaortic approach using right anterior thoracotomy to partial J-sternotomy. (2015) (8)
Clinical Outcomes of Transcatheter Aortic Valve Implantation in Patients With Extremely Large Annulus and SAPIEN 3 Dimensions Based on Post-Procedural Computed Tomography. (2019) (8)
Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement. (2021) (8)
- year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis ( PARTNER 1 ) : a randomised controlled trial (2015) (8)
3D Intracardiac Echocardiography During TAVR Without Endotracheal Intubation. (2016) (8)
Validation of Contrast-Enhanced MRI to Monitor Regenerative Efficacy after Cell Therapy in a Porcine Model of Convalescent Myocardial Infarction Running title: Malliaras et al.; Validation of MRI to assess cardiac regeneration (2013) (8)
High-pressure post-dilation following transcatheter valve-in-valve implantation in small surgical valves. (2018) (7)
Geometric changes in ventriculoaortic complex after transcatheter aortic valve replacement and its association with post-procedural prosthesis–patient mismatch: an intraprocedural 3D-TEE study (2017) (7)
Comparison of long‐term outcomes of drug‐eluting stents and bare metal stents for saphenous vein graft stenosis (2012) (7)
5-Year Follow-Up From the PARTNER 2 Aortic Valve-in-Valve Registry for Degenerated Aortic Surgical Bioprostheses. (2022) (7)
Abstract 18236: Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC): Six Month Safety and Exploratory Efficacy Results (2015) (7)
Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization (2022) (7)
Use of a Dual-Filter Cerebral Embolic Protection Device in Thoracic Endovascular Aortic Repair. (2020) (7)
Effect of cardiosphere-derived cells on segmental myocardial function after myocardial infarction: ALLSTAR randomised clinical trial (2021) (7)
Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement (2020) (7)
Inter- and intrasite variability of mortality and stroke for sites performing both surgical and transcatheter aortic valve replacement for aortic valve stenosis in intermediate-risk patients. (2020) (7)
Transcatheter aortic valve replacement in bicuspid aortic valve stenosis: where do we stand? (2018) (7)
Mesenchymal stem cell therapy prevents deterioration of left ventricular function in a porcine myocardial infarction model (2002) (7)
Prevalence and Prognostic Impact of Ascending Aortic Dilatation in Patients Undergoing TAVR. (2019) (6)
Early Clinical Outcomes of Transcatheter Aortic Valve Replacement in Left Ventricular Outflow Tract Calcification: New-Generation Device vs Early-Generation Device. (2018) (6)
Impact of Annular Oversizing on Paravalvular Regurgitation and Valve Hemodynamics: New Insights From PARTNER 3. (2021) (6)
Real-World Experience With the SAPIEN 3 Ultra Transcatheter Heart Valve (2021) (6)
Leaflet motion abnormality after TAVI: genuine threat or much ado about nothing? (2016) (6)
Repeat Aortic Valve Surgery or Transcatheter Valve-in-Valve Therapy: We Need a Randomized Trial. (2020) (6)
TCT-152 ALLogeneic Heart STem Cells To Achieve Myocardial Regeneration (ALLSTAR): The Six Month Phase I Safety Results (2014) (6)
TCT-688 One Year Results of Tanscatheter Aortic Valve Therapy for Failed Surgical Bioprostheses - PARTNER II Valve-in-Valve Registry (2014) (6)
Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve: Challenges and Pitfalls. (2018) (6)
TCT-36 Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial. (2016) (5)
Might Coronary Flow Influence Transcatheter Heart Valve Neo-Sinus Thrombosis? (2019) (5)
Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the TOPAS-TAVI Registry. (2020) (5)
Transcatheter aortic valve replacement in bicuspid aortic valve stenosis. (2020) (5)
Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis Hospitalized with Acute Heart Failure. (2020) (5)
Summary: International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional, and research purposes. (2021) (5)
Investigation of Computed-Tomography Based Predictors of Acute Stroke Related to Transcatheter Aortic Valve Replacement: Aortic Wall Plaque Thickness Might be a Predictive Parameter of Stroke. (2020) (4)
Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions (2022) (4)
Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement in Severe Mitral Annular Calcification: An Analysis of the Transcatheter Mitral Valve Replacement in Mitral Annular Calcification Global Registry (2021) (4)
Perivalvular Extension of Infective Endocarditis after Transcatheter Aortic Valve Replacement. (2021) (4)
Abstract 14317: Impact of Aortic Valve and Annular Calcification on Paravalvular Aortic Regurgitation After Transcatheter Aortic Valve Replacement: A Real-Time Three-Dimensional Transesophageal Echocardiography Study (2013) (4)
Impact of Mitral Annular Displacement on Left Ventricular Diastolic Function Improvement After Transcatheter Aortic Valve Implantation. (2017) (4)
Anticoagulation Therapy After Transcatheter Aortic Valve Replacement (2020) (4)
Transcatheter Aortic Valve Implantation for a Failed Bio-Bentall in Patients with Marfan Syndrome (2014) (4)
TCT-706 A Collaborative Meta-analysis of the Impact of Mitral Regurgitation on Outcomes after Transcatheter Aortic Valve Replacement: 8 Studies involving 8919 patients (2014) (4)
Abstract 13259: Irrelevance of C-Kit-Positive Subpopulation to the Therapeutic Benefit of Human Cardiosphere-Derived Cells (2012) (4)
Atrial Fibrillation Is Associated With Mortality in Intermediate Surgical Risk Patients With Severe Aortic Stenosis: Analyses From the PARTNER 2A and PARTNER S3i Trials (2021) (4)
Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes in the PARTNER 3 Trial. (2022) (4)
Impact of the Geriatric Nutritional Risk Index in Patients Undergoing Transcatheter Aortic Valve Implantation. (2021) (4)
Single Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Clinical Trials (2021) (4)
Transcatheter aortic valve implantation: patient selection and procedural considerations. (2011) (3)
Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular Calcification. (2019) (3)
Cardiosphere-derived cells for heart regeneration – Authors’ reply (2012) (3)
5-Year Outcomes Comparing Surgical Versus Transcatheter Aortic Valve Replacement in Patients With Chronic Kidney Disease. (2021) (3)
New heparin dosing regimen for diabetics undergoing percutaneous coronary intervention. (2005) (3)
TCT-306 Transcatheter Aortic Valve Replacement with Extremely Large Annuli Greater Than 683 mm2 Using Edwards Sapien 3 Valve – A Multicenter Experience (2017) (3)
Aortic Valve Disease and TreatmentTCT-747 Transcatheter Aortic Valve Replacement: Assessment of the Learning Curve Based on the PARTNER Trial (2013) (3)
Left-Sided Venous Access: A Technique to Simplify and Improve Success of Tricuspid Valve Clip Repair. (2021) (3)
Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis (2018) (3)
Summary: international consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional and research purposes. (2021) (3)
Transcatheter Aortic Valve Implantation With Different Valve Designs for Severe Device Landing Zone Calcification. (2017) (3)
Transcatheter aortic valve replacement for bicuspid aortic valve regurgitation in a 17-year-old patient with congenitally corrected transposition of great arteries: a case report (2020) (3)
Minimally Invasive versus Full Sternotomy for Isolated Aortic Valve Replacement in Low-risk Patients. (2021) (3)
CARDIOPROTECTIVE EFFECT OF ALLOGENEIC CARDIOSPHERE–DERIVED CELLS: REDUCTION OF INFARCT SIZE AND ATTENUATION OF NO–REFLOW WHEN ADMINISTERED IN THE INFARCT–RELATED ARTERY AFTER REPERFUSION IN PIGS WITH ACUTE MYOCARDIAL INFARCTION (2013) (3)
St. Jude Medical Portico™ transapical technology. (2013) (3)
Utilization, Costs, and Outcomes of Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement (2021) (3)
Impact of Pulmonary Artery Dilatation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement. (2021) (3)
Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry. (2013) (3)
Response to Letters Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry". (2015) (3)
1100-55 Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters ventricular electrophysiologic properties (2004) (2)
New-Generation Transcatheter Aortic Valves in Patients With Small Aortic Annuli　- Comparison of Balloon- and Self-Expandable Valves in Asian Patients. (2020) (2)
PACEMAKER DEPENDENCY FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION: A SUBANALYSIS OF THE REPRISE III RANDOMIZED CONTROLLED CLINICAL TRIAL (2018) (2)
Valve-in-Valve TAVI for Degenerated Surgical Prostheses (2010) (2)
MAJOR THROMBOCYTOPENIA AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2013) (2)
Response to Letter Regarding Article, "Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy". (2015) (2)
CLINICAL IMPACT OF NEW LEFT BUNDLE BRANCH BLOCK IN INTERMEDIATE RISK PATIENTS UNDERGOING TAVR: AN ANALYSIS OF THE PARTNER II TRIAL AND REGISTRIES (2018) (2)
Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses: Insights from the PARTNER II Valve-in-Valve Registry on Utilizing Baseline Computed-Tomographic Assessment (2017) (2)
30 DAY OUTCOMES FROM THE PARTNER II TRIAL FOR TRANSAPICAL AND TRANSFEMORAL 29MM TAVR IN INOPERABLE PATIENTS WITH THE EDWARDS SAPIEN XT (2014) (2)
Outcomes of Patients with Significant Obesity Undergoing TAVR or SAVR in the Randomized PARTNER 2A Trial (2018) (2)
Neo-sinus Flow Stasis Correlates with Thrombus Volume in Patients post-TAVR (2019) (2)
ALLOGENEIC CARDIOSPHERE–DERIVED CELLS AFTER REPERFUSION ARE EFFECTS IN REDUCING INFARCT SIZE AND ATTENUATING ADVERSE REMODELING IN PIGS WITH ACUTE MYOCARDIAL INFARCTION (2013) (2)
Infective Endocarditis Caused by Staphylococcus Aureus after Transcatheter Aortic Valve Replacement. (2021) (2)
Usefulness of Computed Tomography to Predict Mitral Stenosis After Transcatheter Mitral Valve Edge-to-Edge Repair. (2021) (2)
Abstract 23079: Clinical Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprostheses (Mitral Valve-in-Valve) and Surgical Rings (Mitral Valve-in-Ring) in the United States: Data From the STS/ACC/TVT Registry (2017) (2)
IMPACT OF PREOPERATIVE MODERATE/SEVERE MITRAL REGURGITATION ON PATIENTS UNDERGOING PERCUTANEOUS AND SURGICAL AORTIC VALVE REPLACEMENT: INSIGHTS FROM THE PARTNER TRIAL (2013) (2)
Mitral Valve Infective Endocarditis after Trans-Catheter Aortic Valve Implantation. (2022) (2)
Transcatheter Aortic Valve Replacement With the St. Jude Medical Portico Valve (2012) (2)
TCT-674 Sex Specific Outcomes of TAVR with the Sapien 3 Valve: Insights From The PARTNER 2 S3 High-Risk and Intermediate-Risk Cohorts. (2016) (2)
Optimal Medical Therapy Following Transcatheter Aortic Valve Implantation. (2020) (2)
Abstract 19038: Neo-Sinus Washout is Faster in Supra-Annular Transcatheter Heart Valves (2017) (2)
Transplantation Therapy With Mesenchymal Stem Cells Prevents Deterioration Of Left Ventricular Function In A Porcine Myocardial Infarction Model (2002) (2)
Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR (2020) (2)
Abstract 16466: Comparison of Cardiac Engraftment With Two Catheter-Based Delivery Methods: Catheter-Mediated Intramyocardial Delivery Outperforms Intracoronary Delivery of Cardiosphere-Derived Cells in Porcine Ischemic Cardiomyopahty (2011) (2)
How should I treat severe paravalvular leakage after TAVI? (2013) (2)
3 YEAR OUTCOMES OF TRANSCATHETER MITRAL VALVE-IN-VALVE, VALVE-IN-RING AND VALVEIN-MITRAL ANNULAR CALCIFICATION: RESULTS FROM THE MITRAL TRIAL (2022) (2)
Transcatheter Aortic Valve Replacement for Bicuspid Aortic Insufficiency After Valve-Sparing Aortic Root Replacement (2021) (2)
Early Leaflet Thrombosis: Is it Benign? (2018) (1)
TCT-95 The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement: A Report from the PARTNER I Trial (2015) (1)
Percutaneous Edge-to-Edge Mitral Valve Repair With the MitraClip System Following Surgical Annuloplasty Ring Dehiscence. (2021) (1)
Abstract 3611: Thymosin Beta-4 (TB4) Enhances Cardiosphere-derived Cardiac Stem Cell (CDC)-mediated Cardioprotection by Promoting CDC Migration and Angiogenesis via Akt Phosphorylation (2009) (1)
Bioprosthetic Valve Thrombosis: Insights from Transcatheter and Surgical Implants (2020) (1)
Summary: International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. (2021) (1)
IMPACT OF MODERATE-SEVERE MITRAL REGURGITATION ON OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: META-ANALYSIS OF 8 STUDIES COMPRISING 6166 PATIENTS (2014) (1)
Doppler Velocity Index Outcomes Following Surgical or Transcatheter Aortic Valve Replacement in the PARTNER Trials. (2021) (1)
IMPACT OF ACUTE KIDNEY INJURY AFTER SURGICAL AND TRANSCATHETER AORTIC VALVE REPLACEMENT IN INTERMEDIATE-RISK PATIENTS WITH CHRONIC KIDNEY DISEASE (2021) (1)
Mesenchymal Stern Cell injection induces cardiac nerve sprouting and tenascin expression in a swine model of myocardial infarction (2002) (1)
Abstract 16451: Dose-Escalation Study Using Novel Continuous Flow Intracoronary Delivery of Allogeneic Cardiosphere-Derived Stem Cells: Is There a Threshold for Cell Therapy? (2014) (1)
1-YEAR RESULTS OF TRANSCATHETER AORTIC VALVE REPLACEMENT IN EXTREMELY LARGE ANNULI >683 MM2 WITH EDWARDS SAPIEN 3 VALVE: A MULTICENTER EXPERIENCE (2019) (1)
ANTITHROMBOTIC THERAPY AND CARDIOVASCULAR RISK IN PATIENTS WITH ATRIAL FIBRILLATION AT HIGH RISK FOR THROMBOEMBOLIC EVENTS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: FROM THE PARTNER 2 TRIAL (2019) (1)
Long-Term Clinical Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Ostial / Midshaft Lesions in Unprotected Left Main Coronary Artery From the DELTA Registry A Multicenter Registry Evaluating Percutaneous Coronary Intervention Versus Coronary Artery Bypas (1)
Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER‐2 (2022) (1)
TCT-652 Outcomes in Patients with Transcatheter Aortic Valve Replacement and Left Main Stent: The multicenter, multinational TAVR-LM Registry (2015) (1)
Post-Conditioning : Allogeneic Cardiosphere-Derived Cells Reduce Infarct Size and Attenuate Microvascular Obstruction When Administered After Reperfusion in Pigs With Acute Myocardial Infarction (2015) (1)
Association of postprocedural aortic regurgitation with mitral regurgitation worsened after transcatheter aortic valve replacement (2018) (1)
Hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) of aortic bioprostheses: An imaging finding or a complication? (2022) (1)
Bivalirudin in acute coronary syndromes and percutaneous coronary intervention. (2006) (1)
TCT CONNECT-468 Postoperative Atrial Fibrillation or Flutter Following Transcatheter or Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients at Low Surgical Risk: An Analysis From the PARTNER 3 Trial (2020) (1)
TCT-743 Stratification of survival after transcatheter aortic valve replacement based on vascular complication by VARC-1 or VARC-2 criteria (2013) (1)
Sustained left ventricular outflow tract ventricular tachycardia following transcatheter aortic valve replacement. (2017) (1)
Recurrent severe aortic stenosis after transfemoral transcatheter valve-in-valve-in-valve replacement. (2018) (1)
CONCENTRIC LEFT VENTRICULAR REMODELING IS ASSOCIATED WITH LOW-FLOW SEVERE AORTIC STENOSIS AND LESS REVERSE REMODELING AFTER TAVR: A PARTNER 2 TRIAL ANALYSIS (2017) (1)
TCT-657 Stentless vs. Stented Aortic Valve-in-Valve Implantation: Insights from the Valve-in-Valve International Data Registry (VIVID). (2015) (1)
TCT-661 The Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights from the PARTNER II SAPIEN 3 Cohort. (2016) (1)
BALLOON-EXPANDABLE TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH EXTREME AORTIC VALVE CALCIFICATION (2015) (1)
ROUTINE EARLY DISCHARGE AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: A PROPENSITY SCORE ANALYSIS FROM THE PARTNER 2 SAPIEN 3 STUDY (2018) (1)
Abstract 17267: Enhanced Engraftment and Therapeutic Benefit of Human Cardiosphere-Derived Cells Delivered in an In Situ Polymerizable Hydrogel (2011) (1)
Transcatheter and Doppler waveform correlation in transcatheter aortic valve replacement (2018) (1)
Abstract 14781: Intracoronary Cardiosphere-Derived Cells for Heart Regeneration after Myocardial Infarction: Determinants of Regenerative Efficacy in the Final 1-Year Results of the CADUCEUS Trial (2012) (1)
PIVOTAL TRIAL OF TRANSENDOCARDIALLY-INJECTED ALLOGENEIC CARDIOSPHERES IN PORCINE ISCHEMIC CARDIOMYOPATHY REVEALS THERAPEUTIC REGENERATION AND BLUNTED ADVERSE VENTRICULAR REMODELING (2013) (1)
Intraprocedural Use of Echocardiography for TAVR (2014) (1)
Transcatheter Aortic Valve Implantation (2011) (1)
Percutaneous coronary intervention in unprotected left main disease: a status report. (2006) (1)
Sex-differences in outcomes after PCI or CABG for left main disease: from the DELTA registries (2020) (1)
Abstract 15558: Clinical Impact of Coronary Protection During Transcatheter Aortic Valve Replacement: First Reported Series of 20 Patients (2014) (1)
TRANSCATHETER AORTIC VALVE REPLACEMENT FOR FAILED SURGICAL BIOPROSTHESES. EARLY RESULTS FROM THE PARTNER II VALVE-IN-VALVE REGISTRY (2014) (1)
Balloon Aortic Valvuloplasty: Is It Still Relevant? (2017) (1)
TCT-42 Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes After Transcatheter and Surgical Aortic Valve Replacement: An Analysis of the PARTNER 3 Trial (2021) (1)
NEO-SINUS FLOW STASIS CORRELATES WITH LEAFLET THROMBOSIS ACROSS MULTIPLE TRANSCATHETER AORTIC VALVES (2020) (1)
A Bicuspid Aortic Valve Imaging Classi ﬁ cation for the TAVR Era (2016) (1)
Clinical and Functional Outcomes Associated With Myocardial Injury After€Transfemoral and Transapical Transcatheter Aortic Valve Replacement (1)
Prospective Feasibility Trial Investigating the se of the Impella 2 . 5 System in Patients ndergoing High-Risk Percutaneous Coronary ntervention ( The PROTECT I Trial ) (2009) (1)
Percutaneous Management of Aortic Root Rupture During Transcatheter Aortic Valve Replacement With Coil Embolization. (2018) (1)
TCT-678 Incidence, Predictors and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation for Degenerative Bioprosthetic Surgical Valves: Insights from the VIVID Registry. (2016) (1)
Update on New Devices for Transcatheter Aortic Valve Replacement (1)
omparison of Coronary Artery Bypass Surgery nd Percutaneous Drug-Eluting Stent mplantation for Treatment of Left Main oronary Artery Stenosis (2008) (1)
TCT-683 Variation in the Timing of Percutaneous Coronary Intervention and Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement (2019) (1)
TCT-419 Complete Percutaneous Approach For Arterial Access And Closure For Device Deployment In The Transfemoral Transcatheter Aortic Valve Replacement - A Comparison With Surgical Cut-down (2012) (1)
CHANGES OF MITRAL REGURGITATION AFTER SURGICAL AORTIC VALVE REPLACEMENT AND TRANSCATHETER AORTIC VALVE IMPLANTATION: A TWO-DIMENSIONAL ECHOCARDIOGRAPHY STUDY (2012) (1)
Hemodynamic and Mid-Term Outcomes for Transcatheter Aortic Valve Replacement in Degenerated Internally Stented Valves. (2023) (1)
Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial Subanalysis. (2019) (1)
Transcatheter Aortic Valve Implantation Three-Dimensional Echo Monitoring and Guidance (2011) (1)
The buddy balloon for transcatheter aortic valve replacement: insights from computed tomographic assessment of the aortic valvular complex. (2013) (1)
TCT-4 Transcatheter Tricuspid Valve Repair in Patients With Functional Tricuspid Regurgitation: 2-Year Outcomes From the FORMA US Early Feasibility Study (2019) (1)
Left Main protection during very high risk Transcatheter Aortic Valve-in-Valve procedure. A Collaborative Registry. (2016) (1)
TCT-115 Predictors and Clinical Consequences of Permanent Pacemaker Implantation after TAVR in the PARTNER Experience (2013) (1)
TCT-347 Neurologic Events in Patients Treated with Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement: Insights from the PARTNER (Placement of Aortic Transcatheter Valves) Trial (2017) (1)
Abstract 15926: Impact of Small Body Surface Area on Para-valvular Leak After Balloon-expandable Transcatheter Aortic Valve Replacement (2015) (0)
Abstract 19031: Comparison of Drug-eluting Stents to Bare Metal Stents for Saphenous Vein Graft Stenosis: Longest Available Follow-up Analysis (2010) (0)
Three-Dimensional Intracardiac Echocardiography for Tricuspid Transcatheter Edge-to-Edge Repair (2022) (0)
Abstract 19074: Multi-Vessel Intracoronary Infusion of Allogeneic Cardiosphere-Derived Cells in a Porcine Model of Myocardial Infarction (2013) (0)
Case-Based Examples of Complications Associated with Transcatheter Aortic Valve Replacement (2014) (0)
RELATIONSHIP BETWEEN MITRAL REGURITATION AND LEFT VENTRICULAR EJECTION FRACTION AND STROKE VOLUME AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2014) (0)
Abstract 18222: Prognostic Value of B-type Natriuretic Peptide in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (2012) (0)
PREDICTORS OF AORTIC ROOT INJURY DURING BALLOON–EXPANDABLE TRANSCATHETER AORTIC VALVE IMPLANTATION (2013) (0)
Abstract 14646: Left Ventricular Global Longitudinal Strain and CT Derived Extracellular Volume Predicts Outcomes in Patients With Low-flow, Low-gradient Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (2020) (0)
Balloon-expandable valve-in-valve for a deformed surgical bioprosthesis. (2020) (0)
TCT CONNECT-464 Risk of Coronary Obstruction Due to Sinus Sequestration in Repeat Transcatheter Aortic Valve Replacement (2020) (0)
Abstract 14478: Left Ventricular (LV) Determinants of Left Atrial (LA) Remodeling in Ischemic Cardiomyopathy (iCM): From the Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (ALLSTAR) Double Blind Placebo Controlled Trial (2020) (0)
TCT-51 Impact of anticoagulation therapy on valve hemodynamics and clinical outcomes after bioprosthetic aortic valve replacement: A pooled analysis of the PARTNER2 trials (2017) (0)
The Janus face of drug-eluting stents. (2006) (0)
OUTCOMES AND SOCIETY OF THORACIC SURGEONS RISK SCORE: A SUBANALYSIS OF THE REPRISE III RANDOMIZED CLINICAL TRIAL (2018) (0)
Abstract 19101: Is Stop-Flow Necessary for Efficacious Intracoronary Cell Delivery? Comparison With Nonocclusive Intracoronary Infusion in a Porcine Model (2013) (0)
FRAME GEOMETRY AND HEMODYNAMIC FINDINGS OF SAPIEN 3 TRANSCATHETER HEART VALVE IN PATIENTS WITH BICUSPID AORTIC VALVE DISEASE (2017) (0)
Abstract 17567: Bicuspid Aortic Valve Disease: Anatomical Characteristics and Stent Frame Geometry Following Sapien 3 Transcatheter Aortic Valve Implantation (2016) (0)
CHARACTERISTICS OF PERSISTENT TRICUSPID REGURGITATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT (2018) (0)
Long-Term Outcomes of Randomized Controlled Trials Comparing Percutaneous Left Atrial Appendage Closure to Oral Anticoagulation for Nonvalvular Atrial Fibrillation: A Meta-Analysis (2022) (0)
Faculty of 1000 evaluation for Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. (2018) (0)
IMPACT OF DEVICE LANDING ZONE CALCIFICATION ON PARAVALVULAR AORTIC REGURGITATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: A REAL-TIME THREE-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY STUDY (2014) (0)
FIVE-YEAR OUTCOMES COMPARING SURGICAL VERSUS TRANSCATHETER AORTIC VALVE REPLACEMENT IN INTERMEDIATE-RISK PATIENTS WITH CHRONIC KIDNEY DISEASE (2021) (0)
P6311Prognostic impact of permanent pacemaker implantation in patients with low left ventricular ejection fraction following transcatheter aortic valve replacement (2018) (0)
Immediate Improvement in Left Atrial Function After Transcatheter Aortic Valve Replacement on Doppler Echocardiography. (2019) (0)
A HIGHLY PREDICTIVE RISK MODEL FOR NEW PERMANENT PACEMAKER IMPLANTATION AFTER BALLOON-EXPANDABLE TRANSCATHETER AORTIC VALVE REPLACEMENT (2016) (0)
Markers of Myocardial Fibrosis by Computed Tomography and Echocardiography and Clinical Outcomes after Transcatheter Aortic Valve Replacement in Patients with Low-Flow, Low-Gradient Aortic Stenosis (2021) (0)
The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification (2022) (0)
Five-Year Outcomes with Transcatheter Aortic-Valve Replacement. Reply. (2020) (0)
THE IMPACT OF VALVULOARTERIAL IMPEDANCE ON THE LEFT VENTRICULAR MYOCARDIAL REGRESSION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: A COMPARISON WITH TRANSVALVULAR MEAN PRESSURE GRADIENT (2018) (0)
CHARACTERISTICS AND CLINICAL OUTCOMES IN PATIENTS WITH PRIOR CHEST RADIATION UNDERGOING TAVR: OBSERVATIONS FROM THE PARTNER 2 TRIAL AND REGISTRIES (2018) (0)
TCT CONNECT-81 Late Outcomes After Transcatheter Aortic Valve Replacement With a Mechanically Expanded Versus Self-Expandable Valve: 4-Year Results From the REPRISE III Randomized Trial (2020) (0)
STRUCTURAL VALVE DETERIORATION OF TRANSCATHETER VERSUS SURGICAL AORTIC VALVES IN PATIENTS WITH CHRONIC KIDNEY DISEASE: INSIGHTS FROM THE PARTNER 2A TRIAL AND SAPIEN 3 INTERMEDIATE RISK REGISTRY (2021) (0)
Abstract 2522: A Meta-analysis Of 2587 Patients Treated With Percutaneous Coronary Intervention Or Coronary Artery Bypass Grafting For Unprotected Left Main Coronary Artery Stenosis. (2008) (0)
Abstract 13323: Impact of Transcatheter Aortic Valve Replacement on the Mitral Valve Apparatus and Mitral Regurgitation: A Real-Time Three-Dimensional Transesophageal Echocardiography Study (2013) (0)
Usefulness of computed tomography to predict residual mitral regurgitation after transcatheter mitral valve edge-to-edge repair. (2022) (0)
D-2 | Cardiac Computed Tomography Angiography Anatomical Characterization of Patients with Primary Aortic Regurgitation (2022) (0)
Islet1, a transcription factor, promotes cardiac differentiation (2009) (0)
CLINICAL IMPLICATIONS OF NEW LEFT BUNDLE BRANCH BLOCK: SUB–ANALYSIS FROM THE PARTNER TRIAL (2013) (0)
30-DAY OUTCOMES OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FOR AORTIC REGURGITATION WITH A NOVEL SELF-EXPANDING PROSTHESIS (2021) (0)
Left ventricular outflow tract area after percutaneous transseptal transcatheter mitral valve implantation: A three‐dimensional transesophageal echocardiography study (2021) (0)
VOLUME REDUCTION OF MITRAL REGURGITATION IS MAIN CONTRIBUTOR TO INCREASE OF CARDIAC FORWARD FLOW AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH PREPROCEDURAL FUNCTIONAL MITRAL REGURGITATION; HEMODYNAMIC ANALYSIS USING ECHOCARDIOGRAPHY (2015) (0)
Clinical Cardiology Stem Cell Applications (2011) (0)
Impact of Resting Heart Rate at 30 Days Following Transcatheter or Surgical Aortic Valve Replacement and Cardiovascular Outcomes: Insights from The PARTNER 2 Trial (2018) (0)
TCT CONNECT-126 Outcomes of Patients With Severe Aortic Stenosis and Left Ventricular Obstruction Undergoing Transcatheter Aortic Valve Replacement (2020) (0)
Human cardiosphere-derived adult stem cells originate within the heart (2009) (0)
Abstract 4300: Incidence, Clinical Characteristics and Implications of Coronary Stent Fracture: A Meta-analysis of 5321 Patients (2009) (0)
TCT-896 Prognostic Value and Predictors Value of Reverse Ventricular Remodeling in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (2012) (0)
Abstract 12730: Cardiosphere-derived Cells Improve Segmental Myocardial Circumferential Strain by Magnetic Resonance Imaging: Results From the Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration Study (2020) (0)
TCT-388 Impact of main branch selection on clinical outcomes after percutaneous coronary intervention for unprotected left main coronary artery disease: a substudy from the DELTA registry. (2013) (0)
TCT-338 Comparison of Re-Do transcatheter aortic valve replacement with valve-in-valve for failed surgical aortic bioprostheses: a multicenter analysis of clinical and long-term outcome (2018) (0)
OUTCOMES OF THE DIFFERENT FLOW/GRADIENT PATTERNS OF AORTIC STENOSIS AFTER AORTIC VALVE REPLACEMENT: INSIGHTS FROM PARTNER 2A TRIAL (2017) (0)
Abstract 11154: Predictors of Improvement of Left Ventricular Diastolic Function After Transcatheter Aortic Valve Replacement in Severe Aortic Stenosis With Preserved Left Ventricular Systolic Function: A Serial Echocardiographic Study (2014) (0)
TCT-389 First Report of Percutaneous Left Atrial Appendage Occlusion With Watchman FLX With TEE Guidance and Zero Contrast (2022) (0)
FEASIBILITY AND SAFETY OF SAPIEN 3 TRANSCATHETER AORTIC VALVE IMPLANTATION WITH MODERATE OR NO PREDILATATION (2016) (0)
BA lloon Expandable vs. SElf Expanding Transcatheter VaLve for Degenerated BioprosthesIs: Design and Rationale of the BASELINE Trial. (2022) (0)
TAVR AGE PARADOX: THE OLDEST PATIENTS HAVE BETTER THAN EXPECTED OUTCOMES IN THE PARTNER STUDY (2016) (0)
TCT-426 CT predictor of periprocedural stroke related to transcatheter aortic valve replacement. (2017) (0)
THE PRESENCE OF A PACEMAKER IS ASSOCIATED WITH INCREASED 1 YEAR MORTALITY AND REHOSPITALIZATION IN THE PARTNER TRIAL (2014) (0)
TCT CONNECT-120 Commissural Alignment After Balloon-Expandable TAVR Is Associated With Improved Hemodynamic Outcomes (2020) (0)
THE RELATIVE PERFORMANCE CHARACTERISTICS AND CORRELATION OF THE LOGISTIC EUROSCORE AND THE SOCIETY OF THORACIC SURGERY SCORE IN THE PARTNER TRIAL (2013) (0)
TCT-679 Diabetes and Clinical Outcomes in Intermediate Risk Patients Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: An Analysis of the PARTNER 2A Trial. (2016) (0)
VALUE OF HOLODIASTOLIC FLOW REVERSAL IN THE DESCENDING AORTA IN PATIENTS WITH POST-PROCEDUAL AORTIC REGURGITATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: AN INTRAOPERATIVE TRANSESOPHAGEAL ECHOCARDIOGRAPHY STUDY (2014) (0)
Abnormal wire’s trajectory during edge-to-edge mitral valve repair—a rare case report of inferior vena cava anomaly (2022) (0)
ANATOMIC PREDICTORS OF CORONARY OBSTRUCTION IN PATIENTS UNDERGOING TAVR FOR NATIVE AORTIC STENOSIS: AN ANAYLSIS OF THE INTERNATIONAL, MULTI-CENTER COBRA-TAVR REGISTRY (2020) (0)
The Authors' Reply. (2017) (0)
TCT-782 Effect of a Mechanical-Expanding vs. Self-Expanding Transcatheter Valve Prosthesis on Health Status in Patients with Severe Aortic Stenosis at High Surgical Risk: Results from the REPRISE III Trial (2017) (0)
THE ROLE OF FEMALE SEX IN THE CONTEMPORARY TREATMENT OF THE LEFT MAIN CORONARY ARTERY INSIGHTS FROM THE W– DELTA (WOMEN– DRUG ELUTING STENT FOR LEFT MAIN CORONARY ARTERY DISEASE) REGISTRY (2013) (0)
The clinical outcomes on percutaneous coronary intervention for ostial and/or midshaft lesions versus distal bifurcation lesions from the DELTA registry: a multicenter registry evaluating percutaneous (2013) (0)
TCT-394 Late Outcomes After Transcatheter Aortic Valve Replacement With a Mechanically Expanded Versus Self-Expandable Valve: Final 5-Year Results From the REPRISE III Randomized Trial (2021) (0)
TCT-420 Major Vascular Complication And Its Management After Complete Percutaneous Arterial Access And Closure In Transfemoral Transcatheter Aortic Valve Replacement (2012) (0)
LOW INCIDENCE OF FEMORAL VASCULAR COMPLICATIONS WITH PRIMARY AND REPEAT PERCLOSE PRE-CLOSING FOR BALLOON AORTIC VALVULOPLASTY: DATA FROM A LARGE PARTNER-CONTEMPORARY SINGLE CENTER SERIES (2011) (0)
PROGNOSTIC IMPACT OF MILD PARAVALVULAR LEAK WITH NO PRE PROCEDURAL AORTIC REGURGITATION FOLLOWING TAVR (2020) (0)
Heart and Circulation (2017) (0)
TCT-521 Hemodynamic and Mortality Outcome for Transcatheter Valve in Degenerated Internally Stented Surgical Valves Compared With Other Degenerated Surgical Valves (2022) (0)
INTERVENT IONS FOR VALVULAR D ISEASE AND HEART FA ILURE (2016) (0)
INFLUENCE OF CHRONIC KIDNEY DISEASE ON LEFT VENTRICULAR REMODELING AND OUTCOMES IN PATIENTS UNDERGOING TRANS-CATHETER OR SURGICAL AORTIC VALVE REPLACEMENT (2015) (0)
Abstract 19884: Determinants and Prognostic Value of Pulmonary Hypertension in Patients Undergoing Trans-catheter or Surgical Aortic Valve Replacement (2014) (0)
Abstract 18790: Therapeutic Efficacy of Cardiosphere-Derived Cells in a Transgenic Mouse Model of Nonischemic Dilated Cardiomyopathy (2013) (0)
MULTISLICE COMPUTED TOMOGRAPHY IMAGING OF TRANS-CATHETER AORTIC VALVE IMPLANTATION IN DIFFERENT BICUSPID AORTIC VALVE ANATOMIES (2016) (0)
Imaging, Treatment Options, Patient Selection, and Outcome Considerations for Patients With Bicuspid Aortic Valve Disease (2022) (0)
TCT-347 Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement for Failed Surgical Aortic Bioprostheses: A Systematic Review and Meta-Analysis (2021) (0)
Transcatheter Aortic Valve Replacement: What the Near-Term Future Holds and What Evidence Is Needed? (2014) (0)
Abstract 19912: Prognostic Value of Restrictive Left Ventricular Filling in Patients Undergoing Trans-catheter or Surgical Aortic Valve Replacement (2014) (0)
TCT-83 Transcatheter Aortic Valve Replacement with Different Valve Designs for Elliptic Aortic Annulus Shape. (2016) (0)
Managing Patients With Moderate Aortic Stenosis. (2023) (0)
TCT-425 Impact of cerebral protection in aortic stenosis patients treated with transcatheter aortic valve replacement on functional and structural integrity of the brain: results of a combined patient-level analysis of three randomized controlled trials (2017) (0)
Reply: Considering All Indicators of Clinical Outcome in Patients Undergoing TAVR. (2022) (0)
Abstract 13641: Allogeneic Cardiosphere-Derived Cells Reduce Infarct Size and Attenuate No-Reflow when Administered in the Infarct-Related Artery after Reperfusion in Pigs with Acute Myocardial Infarction (2012) (0)
TCT-404 Prognostic Impact of Cardiac Damage Across the Spectrum of Aortic Stenosis Severity: Results From a Large Real-World Database (2022) (0)
P1854Clinical implications of physical function and resilience in patients undergoing transcatheter aortic valve implantation (2019) (0)
LEAFLET LENGTH: A NOVEL PREDICTOR FOR CORONARY COMPROMISE AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT? (2013) (0)
TCT-384 The Myocardial Contraction Fraction Predicts Adverse Events after Aortic Valve Replacement: An Analysis of 3,259 Patients from the Pooled PARTNER 2 Database (2017) (0)
Acute MI and Contrast-Enhanced CMR: We Need the Whole Map of the Archipelago, Not Just Half of It! (0)
Sex differences in aortic stenosis: Identification of knowledge gaps for sex-specific personalized medicine (2022) (0)
OUTCOME OF TRANSCATHETER AORTIC VALVE REPLACEMENT USING SAPIEN3 IN PATIENTS WITH EXTRA LARGE AORTIC ANNULUS (2018) (0)
Transcatheter tricuspid valve replacement along with tricuspid paravalvular leak closure in a patient with severe right heart failure and previous transcatheter pulmonary valve replacement. (2016) (0)
Abstract 16606: The Impact of Learning Curve on Success and Adverse Events After Transcatheter Aortic Valve Replacement: A PARTNER Substudy (2013) (0)
Abstract 17015: Prognostic Value of Elevated Pulmonary Artery Pressure in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (2012) (0)
The Impact of Valvuloarterial Impedance on Left Ventricular Geometrical Change after Transcatheter Aortic Valve Replacement: A Comparison between Valvuloarterial Impedance and Mean Pressure Gradient (2020) (0)
Missing Pieces of the Transcatheter Aortic Valve Replacement Subclinical Leaflet Thrombosis Puzzle. (2022) (0)
Transcatheter aortic valve-in-valve implantation to treat aortic Para-valvular regurgitation after TAVI. (2022) (0)
CRT-600.01 Comparison of Valve Performance of the Intra-Annular Self-Expanding Portico™ Transcatheter Aortic Valve With Contemporary Supra-Annular Self-Expanding and Intra-Annular Balloon-Expandable Valves: Insights From the PORTICO IDE Trial (2020) (0)
THE TRANSFEMORAL APPROACH TO TRANSCATHETER AORTIC VALVE REPLACEMENT CAN TREAT THE VAST MAJORITY OF PATIENTS WITH PROGRESSIVE DEVICE ITERATIONS (2013) (0)
First ever transmitral valve in valve replacement in India (2017) (0)
487 Increased CT Angiography-Derived Extracellular Volume Fraction Predicts Less Benefit In Left Ventricular Remodeling And Ejection Fraction After Transcatheter Edge To Edge Repair For Severe Mitral Regurgitation (2022) (0)
Abstract 13658: The Clinical Impact of Diabetes Mellitus on Outcome After Transcatheter Aortic Valve Replacement (2015) (0)
TCT-477 Prevalence and Clinical Impact of Baseline QRS Duration in Patients With Severe Aortic Stenosis Two Years After Aortic Valve Replacement in the PARTNER II Trial (2018) (0)
Abstract 4338: SYNTAX Score Predicts Major Adverse Cardiovascular and Cerebrovascular Event (MACCE)-free Survival, but Not Overall Survival, in Unprotected Left Main Coronary Artery (ULMCA) Patients Undergoing Percutaneous Coronary Revascularization (PCI): 3-Year Follow-up Analysis (2009) (0)
CRT-700.32 One-Year Outcomes for an Intra-Annular Self-Expanding Transcatheter Aortic Valve and Next-Generation Low-Profile Delivery System (2022) (0)
PREDICTIVE VALUE OF CTA-DERIVED SEPTAL EXTRACELLULAR VOLUME FRACTION FOR PACEMAKER IMPLANTATION POST TAVR IN PATIENTS WITH LOW-FLOW, LOW GRADIENT AORTIC STENOSIS (2022) (0)
AORTIC ANGULATION ATTENUATES PROCEDURAL SUCCESS FOLLOWING SELF-EXPANDABLE BUT NOT BALLOON-EXPANDABLE TRANSCATHETER AORTIC VALVE IMPLANTATION (2016) (0)
Late Contained Aortic Root Rupture After Transcatheter Aortic Valve Replacement for Bicuspid Aortic Stenosis. (2019) (0)
TCT-681 Aggressive oversizing of balloon-expandable transcatheter aortic valve replacement: predictor of para valvular leak with severe aortic valvar complex calcification (2015) (0)
Determinants and Outcomes of Acute Transcatheter Valve-in-Valve Therapy orEmbolization (0)
TCT-332 Impact of Ultra-Low Contrast Computed Tomography Compared to Three-Dimensional Transesopageal Echocardiography for Transcatheter Aortic Valve Replacement planning (2015) (0)
TCT-246 Hemodynamic Performance and Patient Prosthesis Mismatch in Small Aortic Annuli: A Comparison of Different Transcatheter Heart Valves (2021) (0)
Abstract 12320: Assessment of Post-Procedural Aortic Regurgitation After Transcatheter Aortic Valve Replacement During the Procedure: An Intraprocedural Transesophageal Echocardiography Study (2014) (0)
Stenting for Left Main Stenosis Ready for everyday practice ? (0)
Percutaneous treatment options for patients with end-stage aortic valve disease (2007) (0)
Leaflet Thrombosis (0)
OUTCOMES AFTER TRANSFEMORAL TAVR FROM THE NON–RANDOMIZED CONTINUED ACCESS REGISTRY OF THE PARTNER TRIAL (2013) (0)
TCT-422 Pre-procedural white matter lesion burden predicts MRI outcomes in transcatheter aortic valve replacement (TAVR): The Sentinel Trial (2017) (0)
Porcelain Ascending Aorta (2020) (0)
Outcomes of Patients with Severe Aortic Stenosis and Left Ventricular Obstruction Undergoing Transcatheter Aortic Valve Implantation. (2020) (0)
TRENDS IN USE AND OUTCOMES OF INTRAVASCULAR IMAGING DURING PCI IN A REAL-WORLD US COHORT, 2008 - 2019 (2022) (0)
Clinical Research on Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Disease: Principles, Challenges, and an Agenda for the Future (2022) (0)
TCT-510 Multislice computed tomography imaging of Sapien 3 transcatheter heart valve implantation in different bicuspid aortic valve anatomies. (2016) (0)
TCT-629 Balloon-Expandable Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Mild Aortic Valve Calcification (2015) (0)
THORACOTOMY CONFERS BETTER ACUTE PROCEDURAL OUTCOME THAN STERNOTOMY FOR TRANSAORTIC TRANSCATHETER AORTIC VALVE REPLACEMENT (2014) (0)
Left-sided Femoral Venous Access for Tricuspid Clip Procedure (2021) (0)
ASSESSMENT OF AORTIC VALVE TISSUE COMPOSITION BY SEMI-AUTOMATED ANALYSIS OF CTA FOR PREDICTING THE NEED FOR PACEMAKER IMPLANTATION IN TAVR PATIENTS (2022) (0)
TCT-106 Atrial Fibrillation is Associated with Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR: Insights From the PARTNER 2A and PARTNER 2 S3i Trials (2017) (0)
TCT-16 Incidence, Outcomes, and Microbiologic Profile of Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from PARTNER (2018) (0)
INTRACARDIAC ECHOCARDIOGRAPHY GUIDED TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT WITHOUT ENDOTRACHEAL INTUBATION (2015) (0)
TCT-677 Stentless vs. Stented Aortic Valve-in-Valve Implantation: Insights from the Valve-in-Valve International Data Registry (VIVID) (2015) (0)
Transcatheter aortic valve implantation in the Asia-Pacific region: is it ready for prime time? (2021) (0)
Abstract 15952: Feasibility and Safety of Balloon Expandable Transcatheter Aortic Valve Implantation With Moderate or No Predilatation (2014) (0)
600 Predictive Model Of Iliofemoral Vascular Complications Following Transfemoral Transcatheter Aortic Valve Replacement: Development And Initial Validation (2022) (0)
Testing of Intra-Myocardial Cell Therapy in a Large Animal Model of Myocardial Infarction (2009) (0)
DIFFERENCES IN CARDIAC REMODELING, HEMODYNAMIC RESPONSE, AND PREDICTORS OF OUTCOMES AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH LOW-FLOW, LOW-GRADIENT AORTIC STENOSIS AND NORMAL-FLOW, LOW-GRADIENT AORTIC STENOSIS: RESULTS FROM THE LARGEST SINGLE-CENTER EXPERIENCE (2019) (0)
Durable Bene fi ts of Cellular Postconditioning : Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction (2016) (0)
Abstract 18185: Regression of Severe Left Ventricular Hypertrophy After Transcatheter Valve Replacement for Aortic Stenosis: Impact on Clinical Outcomes in PARTNER Cohort A (2013) (0)
INSIGHTS INTO TIMING, RISK FACTORS, AND OUTCOMES OF NEUROLOGIC EVENTS AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT IN THE PARTNER-I TRIAL (2015) (0)
Abstract 19882: Incidence, Clinical Outcomes and Factors Influencing Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement - A Meta-Analysis of 93 Studies including 37,836 Patients (2014) (0)
TRANSCATHETER AORTIC VALVE IMPLANTATION WITH SAPIEN XT OR SAPIEN 3 PROSTHESES IN BICUSPID AORTIC VALVE DISEASE (2016) (0)
56-40: Utility of Permanent-Temporary Pacemaker in the Management of Patients Undergoing Transcatheter Aortic Valve Implantation (2016) (0)
Abstract 18982: Percutaneous Coronary Intervention (PCI) is Equivalent to Coronary Artery Bypass Grafting (CABG) for Unprotected Left Main Coronary Artery Disease: 5 year Follow-up Analysis (2010) (0)
IMPACT OF ANNULAR OVERSIZING ON PARAVALVULAR REGURGITATION AND VALVE HEMODYNAMICS: NEW INSIGHTS FROM THE PARTNER 3 TRIAL (2021) (0)
CORONARY FLOW INFLUENCES TRANSCATHETER AORTIC VALVE LEAFLET THROMBOSIS RISK (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Rajendra R. Makkar?

Rajendra R. Makkar is affiliated with the following schools:

Rajendra R. Makkar's Academic­Influence.com Rankings

Why Is Rajendra R. Makkar Influential?

Rajendra R. Makkar's Published Works

Published Works

What Schools Are Affiliated With Rajendra R. Makkar?

Rajendra R. Makkar's AcademicInfluence.com Rankings